Last reviewed · How we verify
Placebo: Oil
Placebo oil serves as an inert control substance with no active pharmacological mechanism.
Placebo oil serves as an inert control substance with no active pharmacological mechanism. Used for Control arm in phase 3 clinical trial (specific indication unknown).
At a glance
| Generic name | Placebo: Oil |
|---|---|
| Also known as | Placebo |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo, oil is used in clinical trials to provide a control arm against which the efficacy and safety of an active investigational drug can be compared. It has no intended molecular target or therapeutic mechanism of action, allowing researchers to isolate the true effects of the test drug from placebo response and natural disease progression.
Approved indications
- Control arm in phase 3 clinical trial (specific indication unknown)
Common side effects
Key clinical trials
- Effects of Probiotics on Respiratory Tract Infections in Children: A Randomized, Placebo-Controlled Interventional Study (PHASE2)
- FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) (PHASE2)
- Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis (PHASE2)
- Heart & Health Study (NA)
- Evaluation of Pain Thresholds in Migraine Patients After Inhalation of Essential Oils: a Randomized Clinical Trial (NA)
- Antiplaque Efficacy and Patient Reported Outcome of Chlorohexidine, Cetylpyridinium Chloride, and Essential Oil Mouthwashes in Orthodontic Patients (NA)
- Colonic Delivery of DIM and Perilla Oil on Gut Hormones and Food Intake in Obesity (NA)
- Effect of the Consumption of Cookies Enriched With Plant Proteins and of a Vitamin D Supplement on the Progression of Sarcopenia in the Elderly (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo: Oil CI brief — competitive landscape report
- Placebo: Oil updates RSS · CI watch RSS
- Universitaire Ziekenhuizen KU Leuven portfolio CI